UPC Case Law
Siemens Healthineers AG and others v Hologic, Inc.
Order of the UPC Court of Appeal of 15 July 2026, UPC CoA 93/2026
UPC Case Law by Pitch, edited by Bart Lieben · Published
TL;DR
The Court of Appeal refused to suspend a Düsseldorf Local Division infringement decision against Siemens Healthineers companies. It held that a first-instance claim construction differing from the appellant's is not manifestly erroneous, and that a court respects the right to be heard if its decision reflects a party's core arguments, even briefly and in different words. Appellants seeking suspensive effect on right-to-be-heard grounds face a high bar.
Key holding
Under Art 76(2) UPCA the right to be heard obliges the court to take note of and give due consideration to the parties' submissions, and to address the essential substance of submissions on a central issue in its reasoning. An infringement must be presumed only where the grounds allow no conclusion other than that the submissions were completely disregarded, or where they capture at most the literal wording but not the meaning of the submissions. The court need not expressly and exhaustively address every argument; at least the parties' core arguments must be reflected in the decision.
Questions decided
- When does an appeal exceptionally get suspensive effect under Art 74(1) UPCA?
- Is a claim construction that differs from the appellant's a manifest error?
- What does the right to be heard under Art 76(2) UPCA require in a decision's reasoning?
- Is an injunction covering 'making' manifestly wrong against defendants who did not manufacture the product?
Full summary
Read the full analyses for free — create a free account
With a free Academy account you read the full analysis of every Court of Appeal decision: the facts and procedure, the issues, the court’s reasoning and the practice points. Your name, an e-mail address and a password; no payment, and you can delete the account yourself at any time.
More on infringement and claim interpretation
- Order · UPC CoA 145/2026
Barco N.V. v Yealink (Xiamen) Network Technology Co., Ltd. and others
The Court of Appeal upheld the Brussels Local Division's refusal to let Barco add a late auxiliary request (AR6) whose claim 1 is identical to dependent claim 9, a claim neither asserted for infringement nor attacked in the counterclaim for revocation.
- Decision · UPC CoA 678/2025
Hurom Co., Ltd. v NUC Electronics Co., Ltd and others
The Court of Appeal upheld the Paris Local Division's revocation of Hurom's juicer patent EP 3 155 936 (as amended) for lack of inventive step, refused Hurom's new auxiliary requests filed only on appeal, and confirmed dismissal of all infringement claims, including those for Poland.
- Decision · UPC CoA 908/2025
Hartmann Packaging A/S v Omni-Pac Ekco GmbH Verpackungsmittel and others
The Court of Appeal rejected Hartmann's infringement and revocation appeals on its egg-package patent EP 2 755 901.
- Order · UPC CoA 87/2026
Lepu Medical Technology (Bejing) Co., Ltd and others v Occlutech GmbH
The Court of Appeal upheld a EUR 58,800 penalty against the Lepu companies for breaching a preliminary injunction (PI), and rejected their appeal in full.
- Order · UPC CoA 692/2025
Nera Innovations Ltd v Xiaomi Communications Co., Ltd. and others
The Court of Appeal excluded from the appeal a private expert report on claim interpretation, an accompanying handbook extract, and a new inventive-step attack based on D1, D2 and D4, because Xiaomi could have filed them at first instance and gave no reason for not doing so.
- Order · UPC CoA 907/2025
Occlutech GmbH v Lepu Medical (Europe) Cooperatief U.A. and others
The Court of Appeal set aside the Düsseldorf Local Division's refusal of provisional measures and itself ordered Lepu to stop offering and marketing its MemoCarna ASD and VSD occluders in Germany, France, Italy and the Netherlands.